Strategic partnership DKSH partnership expansion in Australia and New Zealand presents a channel-led sales opportunity for Standard BioTools to broaden distribution of spatial biology, proteomics, and genomics solutions through a trusted regional partner.

Investor engagement Upcoming virtual annual meeting and stockholder voting indicate ongoing investor confidence and potential for financing discussions, collaborations, or strategic milestones that can be aligned with product launches or customer acquisitions.

Expanded proteomics Recent launches and events around SomaScan enhancements and proteomics roundtables signal growing market interest; target labs and CROs focusing on high-throughput protein measurements as potential early adopters for expanded assay kits and platforms.

Strategic alliances Illumina partnership and broadening portfolio suggest an openness to co-developed solutions; pursue joint demonstrations, integrated workflows, and co-marketing to access broader customer bases in genomics and multi-omics research.

Industry footprint Active participation in major conferences (AACR 2025) and ongoing global distribution efforts imply strong demand for cutting-edge multi-omics tools; sales teams should target academic, pharmaceutical, and biotech R&D segments seeking advanced proteomics and genomics capabilities.